4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-047538
President and COO sold 3,000 shares at an average $8.66 ($25,968)
- President and COO acquired 3,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Larson Tina Marriott · President and COO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-24 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,000 | $1.06 | $3,180 | 421,782 | D |
| 2023-08-24 | Sale : show line 2 in the form 10b5-1 | −2,937 | $8.64 | $25,373 | 418,845 | D |
| 2023-08-24 | Sale : show line 3 in the form 10b5-1 | −63 | $9.45 | $596 | 418,782 | D |
| Open-market sales · 3,000 sh · avg $8.66 · $25,968 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-08-24 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −3,000 | $1.06 | 2028-07-22 | 3,000 | 529,000 | D |
Loading xslF345X05/doc4.xml…